GAITHERSBURG, Md., Aug. 29, 2024 (GLOBE NEWSWIRE) — Emergent BioSolutions Inc. (NYSE: EBS) today announced that the U.S. Food and Drug Administration (FDA) […]
Key Highlights: 2ndQuarter operating netbacks of $5.08/Mcf natural gas and $51.58/bbl condensate ($29.74/boe). Conditionally awarded two Productive Participation Contracts to […]